HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critical role of CD23 in allergen-induced bronchoconstriction in a murine model of allergic asthma.

Abstract
CD23-deficient and anti-CD23 monoclonal antibody-treated mice were used to investigate the role of the low-affinity receptor for IgE (CD23) in allergic airway inflammation and airway hyperresponsiveness (AHR). While there were no significant differences in ovalbumin (OVA)-specific IgE titers and tissue eosinophilia, evaluation of lung function demonstrated that CD23-/- mice showed an increased AHR to methacholine (MCh) when compared to wild-type mice but were completely resistant to the OVA challenge. Anti-CD23 Fab fragment treatment of wild-type mice did not affect the MCh-induced AHR but significantly reduced the OVA-induced airway constriction. These results imply a novel role for CD23 in lung inflammation and suggest that anti-CD23 Fab fragment treatment may be of therapeutic use in allergic asthma.
AuthorsG Dasic, P Juillard, P Graber, S Herren, T Angell, R Knowles, J Y Bonnefoy, M H Kosco-Vilbois, Y Chvatchko
JournalEuropean journal of immunology (Eur J Immunol) Vol. 29 Issue 9 Pg. 2957-67 (09 1999) ISSN: 0014-2980 [Print] Germany
PMID10508270 (Publication Type: Journal Article)
Chemical References
  • Allergens
  • Bronchoconstrictor Agents
  • Receptors, Fc
  • Receptors, IgE
  • Methacholine Chloride
  • Immunoglobulin E
  • Ovalbumin
Topics
  • Allergens (immunology)
  • Animals
  • Asthma (immunology)
  • Bronchoconstriction (immunology)
  • Bronchoconstrictor Agents (pharmacology)
  • Disease Models, Animal
  • Eosinophils (metabolism)
  • Female
  • Immunoglobulin E (biosynthesis)
  • Macrophages, Alveolar (metabolism)
  • Methacholine Chloride (pharmacology)
  • Mice
  • Mice, Congenic
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Ovalbumin (immunology, metabolism)
  • Receptors, Fc (metabolism)
  • Receptors, IgE (deficiency, metabolism, physiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: